Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+6.26%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$251M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$35M |
| 2 |
Merck
MRK
|
+$29.3M |
| 3 |
Microsoft
MSFT
|
+$23.4M |
| 4 |
Occidental Petroleum
OXY
|
+$18.7M |
| 5 |
Yum China
YUMC
|
+$17.1M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$36.6M |
| 2 |
Intel
INTC
|
+$34.3M |
| 3 |
Deere & Co
DE
|
+$18.1M |
| 4 |
NVR
NVR
|
+$17.6M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
Sector Composition
| 1 | Technology | 19.66% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.21% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
751
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $504K | 0.01% |
+22,990
| New | +$504K |
|
752
Cidara Therapeutics
CDTX
$1.62B
| $503K | 0.01% |
3,696
+1,193
| +48% | +$162K |
|
|
SEAC
753
DELISTED
Seachange International Inc
SEAC
| $502K | 0.01% |
6,385
+1,669
| +35% | +$131K |
|
|
LTS
754
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $501K | 0.01% |
158,521
+33,434
| +27% | +$106K |
|
755
Topgolf Callaway Brands
MODG
$1.74B
| $500K | 0.01% |
35,863
| – | – |
|
|
BLCM
756
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $498K | 0.01% |
+5,919
| New | +$498K |
|
757
Procter & Gamble
PG
$370B
| $495K | 0.01% |
5,392
+1,480
| +38% | +$136K |
|
758
Amkor Technology
AMKR
$6.2B
| $494K | 0.01% |
+49,171
| New | +$494K |
|
759
SunCoke Energy
SXC
$655M
| $491K | 0.01% |
+40,986
| New | +$491K |
|
|
MRLN
760
DELISTED
Marlin Business Services Corp
MRLN
| $491K | 0.01% |
21,911
+7,671
| +54% | +$172K |
|
761
Peapack-Gladstone Financial
PGC
$512M
| $484K | 0.01% |
+13,810
| New | +$484K |
|
762
PROS Holdings
PRO
$740M
| $480K | 0.01% |
18,150
+5,340
| +42% | +$141K |
|
|
LUMO
763
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $477K | 0.01% |
6,541
+522
| +9% | +$38.1K |
|
764
Sierra Bancorp
BSRR
$409M
| $476K | 0.01% |
17,910
+3,710
| +26% | +$98.6K |
|
765
SITE Centers
SITC
$474M
| $474K | 0.01% |
41,040
-470,313
| -92% | -$5.43M |
|
766
Travere Therapeutics
TVTX
$2.27B
| $472K | 0.01% |
+22,400
| New | +$472K |
|
767
Boston Scientific
BSX
$155B
| $466K | 0.01% |
+18,810
| New | +$466K |
|
|
ALEX
768
Alexander & Baldwin
ALEX
$1.37B
| $464K | 0.01% |
+16,730
| New | +$464K |
|
769
Conagra Brands
CAG
$9.29B
| $458K | 0.01% |
12,150
+900
| +8% | +$33.9K |
|
770
Omnicom Group
OMC
$14.9B
| $456K | 0.01% |
6,260
-50,725
| -89% | -$3.69M |
|
|
ECYT
771
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $456K | 0.01% |
106,641
+77,600
| +267% | +$332K |
|
772
Halliburton
HAL
$19.1B
| $454K | 0.01% |
+9,300
| New | +$454K |
|
773
Verastem
VSTM
$601M
| $454K | 0.01% |
12,316
-1,050
| -8% | -$38.7K |
|
774
Rocky Brands
RCKY
$216M
| $450K | 0.01% |
23,803
+5,889
| +33% | +$111K |
|
|
ACHN
775
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $449K | 0.01% |
+155,900
| New | +$449K |
|